Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Viking's obesity drug data fuels bets it can rival Lilly's Zepbound

Patients who switched from weekly to monthly injections of VK2735 retained most of their weight loss, with side effects similar to placebo

Viking's obesity drug data fuels bets it can rival Lilly's Zepbound

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at qz.com →

More in Health & Medicine

Liberia: A Decade On - the World Is Still Listening to Liberia's Ebola Story

[Liberian Observer] Ten years after Ebola swept through Liberia and claimed thousands of lives, the world is still turning to this small West African nation for answers.

  • Liberia remains world's go-to source for public health emergency insights a decade after Ebola.
  • LNRCS-trained burial teams managed 3,820 Ebola victims' remains with dignity and respect.
  • Community volunteers played crucial role in contact tracing, preventing transmission chains.

More from Tuesday 22 September →